作者: Brian Kornblit , Yun Chen , Brenda M. Sandmaier
DOI: 10.4161/CHIM.20726
关键词: Treatment options 、 Hematopoietic cell 、 Conditioning 、 Haematopoiesis 、 Oncology 、 Radioimmunotherapy 、 Transplantation 、 Allogeneic hct 、 α emitter 、 Medicine 、 Internal medicine 、 Immunology
摘要: With the introduction of nonmyeloablative conditioning, hematopoietic cell transplantation (HCT) has become a viable treatment option for patients who due to age or comorbidities are ineligible high dose conditioning. However, relapse and toxicities still major problems in HCT. Radioimmunotherapy (RIT)-based conditioning is promising approach that ability specifically target radiation cells. The most widely investigated isotopes β-emitters, but because long path lengths low linear energy transfer, α-emitters which have more favorable physical characteristics, might prove be better alternative. In current study we efficacy safety α-emitter based RIT as only form preclinical model canine allogeneic